492 is the total number of securities Bellevue Group AG has owned. The longest Bellevue Group AG has owned a single stock is 31 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
IONS | IONIS PHARMACEUTICALS INC | 31 | 31 | 0.47% | 3.83% | 9.27% | Q1 2016 | Q3 2023 | 31 |
VRTX | Vertex Pharmaceuticals... | 31 | 31 | 0.50% | 3.01% | 5.88% | Q1 2016 | Q3 2023 | 31 |
NBIX | NEUROCRINE BIOSCIENCES... | 31 | 31 | 0.10% | 2.59% | 5.66% | Q1 2016 | Q3 2023 | 31 |
INCY | Incyte Corporation | 31 | 31 | 0.23% | 2.57% | 5.36% | Q1 2016 | Q3 2023 | 31 |
ISRG | INTUITIVE SURGICAL INC | 31 | 31 | 1.17% | 2.53% | 4.74% | Q1 2016 | Q3 2023 | 31 |
ABT | ABBOTT LABS | 31 | 31 | 1.38% | 2.53% | 4.64% | Q1 2016 | Q3 2023 | 31 |
ANTM | ELEVANCE HEALTH INC | 31 | 31 | 0.35% | 1.97% | 4.33% | Q1 2016 | Q3 2023 | 31 |
UNH | UnitedHealth Group Inc... | 31 | 31 | 0.81% | 1.95% | 3.60% | Q1 2016 | Q3 2023 | 31 |
ALNY | ALNYLAM PHARMACEUTICAL... | 31 | 31 | 0.18% | 1.88% | 3.75% | Q1 2016 | Q3 2023 | 31 |
BSX | Boston Scientific Corp... | 31 | 31 | 0.86% | 1.77% | 2.50% | Q1 2016 | Q3 2023 | 31 |
SYK | STRYKER CORPORATION | 31 | 31 | 0.54% | 1.60% | 3.99% | Q1 2016 | Q3 2023 | 31 |
ILMN | ILLUMINA INC | 31 | 31 | 0.16% | 1.57% | 4.97% | Q1 2016 | Q3 2023 | 31 |
EW | Edwards Lifesciences C... | 31 | 31 | 0.55% | 1.45% | 2.80% | Q1 2016 | Q3 2023 | 31 |
JAZZ | Jazz Pharmaceuticals P... | 31 | 31 | 0.46% | 1.43% | 2.42% | Q1 2016 | Q3 2023 | 31 |
BDX | BECTON DICKINSON & CO | 31 | 31 | 0.64% | 1.27% | 2.76% | Q1 2016 | Q3 2023 | 31 |
HUM | HUMANA INC | 31 | 31 | 0.34% | 1.16% | 2.23% | Q1 2016 | Q3 2023 | 31 |
ESPR | ESPERION THERAPEUTICS ... | 31 | 31 | 0.04% | 1.06% | 4.28% | Q1 2016 | Q3 2023 | 31 |
CNC | Centene Corporation | 31 | 31 | 0.28% | 1.02% | 2.79% | Q1 2016 | Q3 2023 | 31 |
MGNX | MACROGENICS INC | 31 | 31 | 0.28% | 1.01% | 2.03% | Q1 2016 | Q3 2023 | 31 |
AMGN | AMGEN INC | 31 | 31 | 0.07% | 0.98% | 3.87% | Q1 2016 | Q3 2023 | 31 |
GILD | GILEAD SCIENCES INC | 31 | 31 | 0.01% | 0.92% | 3.89% | Q1 2016 | Q3 2023 | 31 |
HOLX | HOLOGIC INC | 31 | 31 | 0.12% | 0.78% | 2.16% | Q1 2016 | Q3 2023 | 31 |
ZBH | ZIMMER BIOMET HOLDINGS... | 31 | 31 | 0.20% | 0.77% | 2.18% | Q1 2016 | Q3 2023 | 31 |
PODD | Insulet Corporation | 31 | 31 | 0.08% | 0.57% | 1.50% | Q1 2016 | Q3 2023 | 31 |
HCA | HCA HOLDINGS INC | 31 | 31 | 0.17% | 0.56% | 1.16% | Q1 2016 | Q3 2023 | 31 |
TMO | THERMO FISHER SCIENTIF... | 31 | 31 | 0.18% | 0.46% | 0.72% | Q1 2016 | Q3 2023 | 31 |
COO | COOPER COS INC | 31 | 31 | 0.10% | 0.41% | 0.76% | Q1 2016 | Q3 2023 | 31 |
GMED | GLOBUS MED INC | 31 | 31 | 0.16% | 0.40% | 0.67% | Q1 2016 | Q3 2023 | 31 |
PEN | PENUMBRA INC | 31 | 31 | 0.06% | 0.33% | 1.15% | Q1 2016 | Q3 2023 | 31 |
RMD | RESMED INC | 31 | 31 | 0.08% | 0.28% | 1.04% | Q1 2016 | Q3 2023 | 31 |
LH | LABORATORY CRP OF AMER... | 31 | 31 | 0.01% | 0.25% | 1.15% | Q1 2016 | Q3 2023 | 31 |
CVS | CVS Health Corporation | 31 | 31 | 0.02% | 0.24% | 1.62% | Q1 2016 | Q3 2023 | 31 |
MCK | McKesson Corporation | 31 | 31 | 0.01% | 0.18% | 1.23% | Q1 2016 | Q3 2023 | 31 |
NVRO | NEVRO CORP | 31 | 31 | 0.06% | 0.17% | 0.44% | Q1 2016 | Q3 2023 | 31 |
MDT | MEDTRONIC PLC | 30 | 30 | 0.42% | 1.81% | 4.61% | Q2 2016 | Q3 2023 | 30 |
BIIB | BIOGEN INC | 17 | 13 | 0.00% | 1.07% | 3.62% | Q1 2016 | Q3 2023 | 30 |
BAX | BAXTER INTL INC | 30 | 30 | 0.14% | 0.87% | 1.72% | Q1 2016 | Q2 2023 | 30 |
AGIO | AGIOS PHARMACEUTICALS INC | 18 | 11 | 0.10% | 1.37% | 3.04% | Q1 2016 | Q3 2023 | 29 |
DXCM | DEXCOM INC | 28 | 1 | 0.23% | 0.94% | 2.62% | Q1 2016 | Q3 2023 | 29 |
REGN | Regeneron Pharmaceutic... | 16 | 13 | 0.13% | 0.77% | 2.76% | Q1 2016 | Q3 2023 | 29 |
EXEL | EXELIXIS INC | 20 | 9 | 0.11% | 0.58% | 1.42% | Q1 2016 | Q3 2023 | 29 |
MOH | MOLINA HEALTHCARE INC | 29 | 29 | 0.10% | 0.50% | 1.17% | Q3 2016 | Q3 2023 | 29 |
DHR | DANAHER CORPORATION | 28 | 28 | 0.55% | 1.37% | 2.48% | Q4 2016 | Q3 2023 | 28 |
NKTR | NEKTAR THERAPEUTICS | 28 | 28 | 0.00% | 0.60% | 1.60% | Q1 2016 | Q4 2022 | 28 |
TFX | TELEFLEX INCORPORATED | 28 | 28 | 0.08% | 0.32% | 0.56% | Q1 2016 | Q4 2022 | 28 |
ALGN | ALIGN TECHNOLOGY INC | 27 | 27 | 0.22% | 1.75% | 5.24% | Q1 2017 | Q3 2023 | 27 |
TDOC | TELADOC INC | 27 | 27 | 0.07% | 0.92% | 4.20% | Q1 2017 | Q3 2023 | 27 |
BMY | Bristol-Myers Squibb C... | 21 | 5 | 0.00% | 0.82% | 2.13% | Q1 2016 | Q1 2023 | 26 |
ABMD | ABIOMED INC | 26 | 26 | 0.24% | 0.73% | 1.50% | Q2 2016 | Q3 2022 | 26 |
HCM | HUTCHMED CHINA LTD | 26 | 26 | 0.08% | 0.43% | 1.01% | Q2 2017 | Q3 2023 | 26 |
BMRN | BIOMARIN PHARMACEUTICA... | 12 | 3 | 0.03% | 0.37% | 1.10% | Q1 2016 | Q3 2023 | 26 |
JNJ | JOHNSON & JOHNSON | 13 | 1 | 0.02% | 0.29% | 1.14% | Q1 2016 | Q3 2023 | 26 |
PFE | PFIZER INC | 11 | 1 | 0.01% | 0.19% | 0.62% | Q1 2016 | Q3 2023 | 26 |
ITCI | INTRA-CELLULAR THERAPI... | 18 | 7 | 0.04% | 1.28% | 2.89% | Q2 2017 | Q3 2023 | 25 |
HALO | HALOZYME THERAPEUTICS INC | 16 | 9 | 0.15% | 1.02% | 2.67% | Q1 2016 | Q1 2023 | 25 |
SAGE | SAGE THERAPEUTICS INC | 24 | 24 | 0.07% | 1.29% | 4.13% | Q4 2017 | Q3 2023 | 24 |
OMCL | OMNICELL INC | 24 | 24 | 0.09% | 0.38% | 0.68% | Q4 2017 | Q3 2023 | 24 |
MASI | Masimo Corporation | 24 | 24 | 0.12% | 0.30% | 0.75% | Q1 2016 | Q4 2021 | 24 |
ABBV | ABBVIE INC | 16 | 8 | 0.00% | 0.28% | 0.98% | Q1 2016 | Q3 2023 | 24 |
RARE | Ultragenyx Pharmaceuti... | 14 | 10 | 0.02% | 0.15% | 0.62% | Q1 2016 | Q2 2022 | 24 |
RDUS | RADIUS HEALTH INC | 14 | 9 | 0.06% | 1.00% | 3.29% | Q1 2016 | Q2 2022 | 23 |
INSM | INSMED INC | 23 | 23 | 0.27% | 0.79% | 1.29% | Q1 2018 | Q3 2023 | 23 |
ALXN | ALEXION PHARMACEUTICAL... | 22 | 22 | 0.03% | 1.66% | 3.00% | Q1 2016 | Q2 2021 | 22 |
TNDM | TANDEM DIABETES CARE INC | 22 | 22 | 0.18% | 0.67% | 1.51% | Q2 2018 | Q3 2023 | 22 |
INSP | INSPIRE MED SYS INC | 22 | 22 | 0.15% | 0.66% | 1.65% | Q2 2018 | Q3 2023 | 22 |
IDXX | IDEXX LABS INC | 22 | 22 | 0.13% | 0.49% | 0.82% | Q2 2018 | Q3 2023 | 22 |
VEEV | VEEVA SYSTEMS INC | 22 | 22 | 0.07% | 0.37% | 0.76% | Q2 2018 | Q3 2023 | 22 |
XENT | INTERSECT ENT INC | 22 | 22 | 0.10% | 0.28% | 0.72% | Q1 2016 | Q2 2021 | 22 |
BGNE | BEIGENE LTD | 17 | 5 | 0.01% | 0.27% | 1.06% | Q4 2017 | Q3 2023 | 22 |
CDNA | CAREDX INC | 21 | 21 | 0.02% | 0.50% | 0.99% | Q3 2018 | Q3 2023 | 21 |
AMED | AMEDISYS INC | 21 | 21 | 0.14% | 0.41% | 1.15% | Q3 2018 | Q3 2023 | 21 |
ICPT | Intercept Pharmaceutic... | 21 | 21 | 0.00% | 0.36% | 1.40% | Q1 2016 | Q1 2021 | 21 |
XRAY | DENTSPLY SIRONA INC | 21 | 21 | 0.09% | 0.20% | 0.39% | Q1 2017 | Q1 2022 | 21 |
ACAD | ACADIA PHARMACEUTICALS... | 12 | 9 | 0.02% | 0.15% | 0.69% | Q1 2016 | Q2 2021 | 21 |
ARGX | ARGENX SE | 20 | 20 | 0.08% | 3.32% | 7.22% | Q4 2018 | Q3 2023 | 20 |
EVH | EVOLENT HEALTH INC | 20 | 20 | 0.06% | 0.76% | 1.61% | Q4 2018 | Q3 2023 | 20 |
MRK | MERCK & CO. INC. | 13 | 1 | 0.00% | 0.21% | 0.58% | Q1 2016 | Q3 2023 | 20 |
GH | GUARDANT HEALTH INC | 20 | 20 | 0.03% | 0.20% | 0.49% | Q4 2018 | Q3 2023 | 20 |
QTNT | QUOTIENT LTD | 20 | 20 | 0.03% | 0.14% | 0.39% | Q1 2016 | Q4 2020 | 20 |
HRC | HILL-ROM HOLDINGS INC | 19 | 19 | 0.39% | 0.89% | 1.50% | Q1 2017 | Q3 2021 | 19 |
CI | THE CIGNA GROUP | 19 | 19 | 0.20% | 0.75% | 1.47% | Q1 2019 | Q3 2023 | 19 |
SWAV | SHOCKWAVE MED INC | 19 | 19 | 0.06% | 0.63% | 1.10% | Q1 2019 | Q3 2023 | 19 |
SUPN | SUPERNUS PHARMACEUTICA... | 10 | 2 | 0.02% | 0.53% | 1.67% | Q1 2016 | Q3 2023 | 19 |
SGEN | SEATTLE GENETICS INC | 19 | 19 | 0.07% | 0.25% | 0.52% | Q1 2016 | Q3 2020 | 19 |
GWPH | GW PHARMACEUTICALS PLC | 19 | 19 | 0.02% | 0.18% | 0.76% | Q3 2016 | Q1 2021 | 19 |
VAR | VARIAN MED SYS INC | 19 | 19 | 0.01% | 0.09% | 0.54% | Q1 2016 | Q3 2020 | 19 |
MRNA | MODERNA INC | 18 | 18 | 1.18% | 3.26% | 6.75% | Q2 2019 | Q3 2023 | 18 |
FATE | FATE THERAPEUTICS INC | 18 | 18 | 0.02% | 1.06% | 2.28% | Q2 2019 | Q3 2023 | 18 |
CRSP | CRISPR THERAPEUTICS AG | 18 | 18 | 0.49% | 0.87% | 1.60% | Q2 2019 | Q3 2023 | 18 |
PACB | PACIFIC BIOSIENCES CAL... | 17 | 1 | 0.23% | 0.61% | 1.43% | Q3 2018 | Q3 2023 | 18 |
SRRK | SCHOLAR ROCK HOLDING CORP | 18 | 18 | 0.17% | 0.53% | 1.27% | Q2 2019 | Q3 2023 | 18 |
SRPT | SAREPTA THERAPEUTICS INC | 9 | 3 | 0.02% | 0.47% | 1.29% | Q3 2018 | Q3 2023 | 18 |
SILK | SILK ROAD MEDICAL INC | 18 | 18 | 0.08% | 0.40% | 0.71% | Q2 2019 | Q3 2023 | 18 |
CHRS | COHERUS BIOSCIENCES INC | 13 | 5 | 0.02% | 0.37% | 1.11% | Q1 2016 | Q4 2020 | 18 |
WVE | WAVE LIFE SCIENCES LTD | 18 | 18 | 0.11% | 0.30% | 0.68% | Q2 2019 | Q3 2023 | 18 |
QTRX | QUANTERIX CORP | 18 | 18 | 0.01% | 0.26% | 0.50% | Q4 2017 | Q1 2022 | 18 |
KOS | KOSMOS ENERGY LTD | 18 | 18 | 0.00% | 0.02% | 0.04% | Q2 2019 | Q3 2023 | 18 |
ARVN | ARVINAS INC | 17 | 17 | 0.32% | 1.18% | 2.13% | Q3 2019 | Q3 2023 | 17 |
ABC | CENCORA INC | 9 | 1 | 0.02% | 0.84% | 2.02% | Q1 2016 | Q3 2023 | 17 |
CRL | CHARLES RIV LABS INTL INC | 17 | 17 | 0.02% | 0.64% | 1.10% | Q3 2019 | Q3 2023 | 17 |
BIO | BIO RAD LABS INC | 17 | 17 | 0.04% | 0.51% | 0.79% | Q3 2019 | Q3 2023 | 17 |
KZR | KEZAR LIFE SCIENCES INC | 17 | 17 | 0.00% | 0.31% | 0.90% | Q2 2019 | Q2 2023 | 17 |
ALKS | Alkermes Public Limite... | 10 | 1 | 0.02% | 0.26% | 0.94% | Q1 2016 | Q3 2023 | 17 |
PHR | PHREESIA INC | 17 | 17 | 0.10% | 0.24% | 0.39% | Q3 2019 | Q3 2023 | 17 |
TXG | 10X GENOMICS INC | 17 | 17 | 0.09% | 0.24% | 0.44% | Q3 2019 | Q3 2023 | 17 |
WMGI | Wright Medical Group Inc. | 16 | 16 | 0.05% | 0.77% | 1.47% | Q1 2016 | Q4 2019 | 16 |
GNMK | GENMARK DIAGNOSTICS INC. | 16 | 16 | 0.19% | 0.46% | 0.92% | Q1 2017 | Q4 2020 | 16 |
IRTC | IRHYTHM TECHNOLOGIES INC | 16 | 16 | 0.12% | 0.25% | 0.49% | Q2 2017 | Q1 2021 | 16 |
GKOS | GLAUKOS CORP | 10 | 6 | 0.07% | 0.24% | 0.47% | Q4 2016 | Q3 2021 | 16 |
TRHC | TABULA RASA HEALTHCARE... | 16 | 16 | 0.07% | 0.21% | 0.45% | Q2 2017 | Q1 2021 | 16 |
BLUE | BLUEBIRD BIO INC | 14 | 2 | 0.02% | 0.21% | 0.37% | Q1 2016 | Q1 2020 | 16 |
MRTX | MIRATI THERAPEUTICS INC | 16 | 16 | 0.01% | 0.04% | 0.11% | Q2 2018 | Q1 2022 | 16 |
IPGP | IPG PHOTONICS CORP | 16 | 16 | 0.00% | 0.00% | 0.01% | Q2 2019 | Q1 2023 | 16 |
CELG | Celgene Corporation | 15 | 15 | 0.09% | 3.48% | 5.07% | Q1 2016 | Q3 2019 | 15 |
AXNX | AXONICS MODULATION TEC... | 15 | 15 | 0.09% | 1.19% | 2.22% | Q1 2020 | Q3 2023 | 15 |
MYOV | MYOVANT SCIENCES LTD | 15 | 15 | 0.47% | 1.13% | 2.12% | Q2 2019 | Q4 2022 | 15 |
TEVA | Teva Pharmaceuticals I... | 12 | 3 | 0.02% | 0.87% | 2.17% | Q1 2016 | Q1 2020 | 15 |
LLY | LILLY ELI & CO | 8 | 1 | 0.00% | 0.74% | 2.16% | Q1 2016 | Q3 2023 | 15 |
ALDR | ALDER BIOPHARMACEUTICA... | 15 | 15 | 0.04% | 0.52% | 1.58% | Q1 2016 | Q3 2019 | 15 |
IART | INTEGRA LIFESCIENCES H... | 15 | 15 | 0.08% | 0.47% | 1.05% | Q1 2017 | Q3 2020 | 15 |
MTEM | MOLECULAR TEMPLATES INC | 15 | 15 | 0.05% | 0.47% | 1.09% | Q4 2019 | Q2 2023 | 15 |
CERN | Cerner Corporation | 12 | 3 | 0.01% | 0.43% | 1.10% | Q1 2016 | Q4 2019 | 15 |
BDTX | BLACK DIAMOND THERAPEU... | 15 | 15 | 0.11% | 0.38% | 0.84% | Q1 2020 | Q3 2023 | 15 |
IQV | IQVIA HOLDINGS INC | 15 | 15 | 0.00% | 0.32% | 0.52% | Q1 2020 | Q3 2023 | 15 |
HZNP | HORIZON THERAPEUTICS P... | 15 | 15 | 0.02% | 0.25% | 0.46% | Q2 2019 | Q4 2022 | 15 |
FIXX | HOMOLOGY MEDICINES INC | 15 | 15 | 0.03% | 0.24% | 0.54% | Q2 2019 | Q4 2022 | 15 |
AVTR | AVANTOR INC | 15 | 15 | 0.05% | 0.14% | 0.22% | Q2 2019 | Q4 2022 | 15 |
ZLAB | ZAI LAB LTD | 12 | 3 | 0.02% | 0.10% | 0.21% | Q1 2019 | Q1 2023 | 15 |
MKTX | MARKETAXESS HOLDINGS INC | 15 | 15 | 0.00% | 0.00% | 0.01% | Q2 2019 | Q4 2022 | 15 |
MYL | MYLAN N V | 12 | 2 | 0.02% | 0.94% | 1.84% | Q2 2016 | Q4 2019 | 14 |
CAH | CARDINAL HEALTH INC | 10 | 1 | 0.00% | 0.57% | 2.77% | Q1 2016 | Q1 2023 | 14 |
GBIO | GENERATION BIO CO | 14 | 14 | 0.19% | 0.44% | 0.80% | Q2 2020 | Q3 2023 | 14 |
TMDX | TRANSMEDICS GROUP INC | 14 | 14 | 0.11% | 0.32% | 0.73% | Q2 2020 | Q3 2023 | 14 |
HMSY | HMS HLDGS CORP | 14 | 14 | 0.09% | 0.26% | 0.47% | Q2 2017 | Q3 2020 | 14 |
INGN | INOGEN INC | 14 | 14 | 0.06% | 0.16% | 0.37% | Q2 2018 | Q3 2021 | 14 |
RDY | DR. REDDYS LABS LTD | 14 | 14 | 0.01% | 0.03% | 0.09% | Q2 2020 | Q3 2023 | 14 |
EL | LAUDER ESTEE COS INC | 14 | 14 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2022 | 14 |
SWKS | SKYWORKS SOLUTIONS INC | 14 | 14 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2022 | 14 |
RLAY | RELAY THERAPEUTICS INC | 13 | 13 | 0.66% | 0.96% | 1.36% | Q3 2020 | Q3 2023 | 13 |
LGND | LIGAND PHARMCEUTICALS INC | 12 | 1 | 0.03% | 0.95% | 2.59% | Q1 2016 | Q4 2019 | 13 |
EXAS | EXACT SCIENCES CORP | 13 | 13 | 0.30% | 0.65% | 1.35% | Q3 2020 | Q3 2023 | 13 |
ACCD | ACCOLADE INC | 13 | 13 | 0.11% | 0.62% | 0.91% | Q3 2020 | Q3 2023 | 13 |
AGN | ALLERGAN PLC | 11 | 2 | 0.09% | 0.56% | 1.53% | Q2 2016 | Q3 2019 | 13 |
OM | OUTSET MED INC | 13 | 13 | 0.06% | 0.48% | 1.06% | Q3 2020 | Q3 2023 | 13 |
APLS | APELLIS PHARMACUETICAL... | 12 | 1 | 0.02% | 0.45% | 1.06% | Q1 2020 | Q3 2023 | 13 |
LEGN | LEGEND BIOTECH CORP | 12 | 1 | 0.08% | 0.26% | 0.49% | Q2 2020 | Q3 2023 | 13 |
ANGO | ANGIODYNAMICS INC | 13 | 13 | 0.10% | 0.22% | 0.41% | Q1 2016 | Q1 2019 | 13 |
VCRA | VOCERA COMMUNICATONS INC | 13 | 13 | 0.08% | 0.22% | 0.78% | Q4 2018 | Q4 2021 | 13 |
CLLS | CELLECTIS S A | 8 | 5 | 0.01% | 0.05% | 0.16% | Q4 2017 | Q4 2021 | 13 |
A | AGILENT TECHNOLOGIES INC | 11 | 2 | 0.00% | 0.02% | 0.06% | Q2 2019 | Q4 2022 | 13 |
CI | CIGNA CORPORATION | 12 | 12 | 0.64% | 1.34% | 2.24% | Q1 2016 | Q4 2018 | 12 |
RVMD | REVOLUTION MEDICINES INC | 12 | 12 | 0.02% | 1.10% | 2.11% | Q4 2020 | Q3 2023 | 12 |
LIVN | LIVANOVA PLC | 12 | 12 | 0.15% | 0.73% | 1.23% | Q1 2017 | Q4 2019 | 12 |
HZNP | HORIZON PHARMA PLC | 8 | 4 | 0.08% | 0.51% | 1.21% | Q1 2016 | Q1 2019 | 12 |
BEAM | BEAM THERAPEUTICS INC | 12 | 12 | 0.27% | 0.42% | 0.77% | Q4 2020 | Q3 2023 | 12 |
ATRC | ATRICURE INC | 12 | 12 | 0.29% | 0.39% | 0.53% | Q4 2020 | Q3 2023 | 12 |
MRSN | MERSANA THERAPEUTICS INC | 12 | 12 | 0.11% | 0.33% | 0.59% | Q4 2020 | Q3 2023 | 12 |
ENDP | ENDO INTL PLC | 12 | 12 | 0.04% | 0.25% | 0.87% | Q1 2016 | Q4 2018 | 12 |
HCAT | HEALTH CATALYST INC | 12 | 12 | 0.09% | 0.23% | 0.41% | Q3 2019 | Q2 2022 | 12 |
HCSG | HEALTHCARE SVCS GRP INC | 12 | 12 | 0.04% | 0.19% | 0.33% | Q1 2016 | Q4 2018 | 12 |
BNTX | BIONTECH SE | 12 | 12 | 0.02% | 0.18% | 0.44% | Q2 2020 | Q1 2023 | 12 |
AMWL | AMERICAN WELL CORP | 12 | 12 | 0.03% | 0.15% | 0.34% | Q3 2020 | Q2 2023 | 12 |
PTLA | PORTOLA PHARMACEUTICAL... | 11 | 1 | 0.02% | 0.14% | 0.24% | Q3 2016 | Q3 2019 | 12 |
SGEN | SEAGEN INC | 12 | 12 | 0.04% | 0.07% | 0.12% | Q4 2020 | Q3 2023 | 12 |
QURE | UNIQURE NV | 12 | 12 | 0.01% | 0.04% | 0.13% | Q2 2018 | Q1 2021 | 12 |
SEER | SEER INC | 12 | 12 | 0.00% | 0.03% | 0.06% | Q4 2020 | Q3 2023 | 12 |
KURA | KURA ONCOLOGY INC | 5 | 2 | 0.01% | 0.02% | 0.05% | Q1 2019 | Q2 2022 | 12 |
CTLT | CATALENT INC | 11 | 1 | 0.00% | 0.02% | 0.05% | Q2 2019 | Q3 2022 | 12 |
MELI | MERCADOLIBRE INC | 11 | 1 | 0.00% | 0.00% | 0.01% | Q2 2019 | Q4 2022 | 12 |
SHPG | SHIRE PLC | 11 | 11 | 0.68% | 1.03% | 1.52% | Q1 2016 | Q3 2018 | 11 |
OPCH | OPTION CARE HEALTH INC | 11 | 11 | 0.28% | 0.90% | 1.19% | Q1 2021 | Q3 2023 | 11 |
AKCA | AKCEA THERAPEUTICS INC | 11 | 11 | 0.08% | 0.70% | 1.24% | Q1 2018 | Q3 2020 | 11 |
AET | AETNA INC NEW | 11 | 11 | 0.09% | 0.51% | 0.94% | Q1 2016 | Q3 2018 | 11 |
ESRX | Express Scripts Holdin... | 11 | 11 | 0.27% | 0.49% | 0.93% | Q1 2016 | Q3 2018 | 11 |
QGEN | QIAGEN NV | 8 | 3 | 0.08% | 0.43% | 1.38% | Q2 2017 | Q1 2020 | 11 |
EPIX | ESSA PHARMA INC | 11 | 11 | 0.15% | 0.40% | 0.74% | Q1 2021 | Q3 2023 | 11 |
VYGR | VOYAGER THERAPEUTICS INC | 8 | 3 | 0.00% | 0.40% | 1.25% | Q2 2018 | Q1 2021 | 11 |
NUVA | NUVASIVE INC | 9 | 2 | 0.05% | 0.34% | 0.72% | Q1 2016 | Q3 2020 | 11 |
OXFD | OXFORD IMMUNOTEC GLOBA... | 11 | 11 | 0.12% | 0.19% | 0.50% | Q2 2018 | Q4 2020 | 11 |
HSIC | SCHEIN HENRY INC | 10 | 1 | 0.00% | 0.19% | 0.33% | Q3 2017 | Q1 2023 | 11 |
UTHR | United Therapeutics Co... | 8 | 3 | 0.00% | 0.16% | 0.42% | Q1 2016 | Q4 2022 | 11 |
CLVS | CLOVIS ONCOLOGY INC | 8 | 1 | 0.01% | 0.13% | 0.28% | Q1 2016 | Q1 2020 | 11 |
SYNH | SYNEOS HEALTH INC | 5 | 2 | 0.02% | 0.06% | 0.13% | Q2 2018 | Q4 2021 | 11 |
OLK | OLINK HOLDING AB | 11 | 11 | 0.04% | 0.06% | 0.08% | Q1 2021 | Q3 2023 | 11 |
ENTG | ENTEGRIS INC | 11 | 11 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2021 | 11 |
JD | JD.COM INC | 11 | 11 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2021 | 11 |
EA | ELECTRONIC ARTS INC | 11 | 11 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2021 | 11 |
GGG | GRACO INC | 11 | 11 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2021 | 11 |
MKL | MARKEL CORP | 11 | 11 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2021 | 11 |
LYV | LIVE NATION ENTERTAINM... | 11 | 11 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2021 | 11 |
AXP | AMERICAN EXPRESS CO | 11 | 11 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2021 | 11 |
AZPN | ASPEN TECHNOLOGY INC | 11 | 11 | 0.00% | 0.00% | 0.01% | Q2 2019 | Q4 2021 | 11 |
PRGO | PERRIGO CO PLC | 9 | 1 | 0.02% | 0.54% | 0.86% | Q1 2016 | Q1 2020 | 10 |
AXSM | AXSOME THERAPEUTICS INC | 10 | 10 | 0.23% | 0.40% | 0.71% | Q2 2021 | Q3 2023 | 10 |
PRVA | PRIVIA HEALTH GROUP INC | 10 | 10 | 0.13% | 0.26% | 0.42% | Q2 2021 | Q3 2023 | 10 |
DVA | DAVITA INC | 6 | 4 | 0.08% | 0.25% | 0.48% | Q1 2016 | Q1 2021 | 10 |
ONEM | 1LIFE HEALTHCARE INC | 10 | 10 | 0.09% | 0.20% | 0.34% | Q1 2020 | Q2 2022 | 10 |
BLI | BERKELEY LTS INC | 10 | 10 | 0.01% | 0.09% | 0.20% | Q3 2020 | Q4 2022 | 10 |
MYGN | MYRIAD GENETICS INC | 9 | 1 | 0.03% | 0.05% | 0.10% | Q1 2016 | Q4 2018 | 10 |
XNCR | XENCOR INC | 10 | 10 | 0.01% | 0.02% | 0.02% | Q4 2020 | Q1 2023 | 10 |
FAST | FASTENAL CO | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
MTD | METTLER TOLEDO INTERNA... | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
DPZ | DOMINOS PIZZA INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
MCO | MOODYS CORP | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
SPGI | S&P GLOBAL INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
WSO | WATSCO INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
POOL | POOL CORPORATION | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
TRMB | TRIMBLE INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
MKC | MCCORMICK & CO INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
MSCI | MSCI INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
TYL | TYLER TECHNOLOGIES INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
BFB | BROWN FORMAN CORP | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
ICE | INTERCONTINENTAL EXCHA... | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
ANSS | ANSYS INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
VRSN | VERISIGN INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
ST | SENSATA TECHNOLOGIES H... | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
VRSK | VERISK ANALYTICS INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
WAB | WABTEC CORP | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
CLX | CLOROX CO DEL | 10 | 10 | 0.00% | 0.01% | 0.01% | Q3 2019 | Q4 2021 | 10 |
SBUX | STARBUCKS CORP | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
BKNG | BOOKING HOLDINGS INC | 10 | 10 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2021 | 10 |
OPT | OPTHEA LTD | 10 | 10 | 0.00% | 0.00% | 0.01% | Q4 2020 | Q1 2023 | 10 |
JMIA | JUMIA TECHNOLOGIES AG | 10 | 10 | 0.00% | 0.00% | 0.01% | Q1 2021 | Q2 2023 | 10 |
WBA | WALGREENS BOOTS ALLIAN... | 9 | 9 | 0.81% | 1.51% | 2.25% | Q1 2017 | Q1 2019 | 9 |
EARS | Auris Medical Holding AG | 9 | 9 | 0.03% | 0.57% | 1.71% | Q1 2016 | Q1 2018 | 9 |
EGRX | EAGLE PHARMACEUTICALS INC | 9 | 9 | 0.08% | 0.46% | 1.23% | Q3 2016 | Q3 2018 | 9 |
IBB | iSHARES Trust | 8 | 1 | 0.12% | 0.32% | 0.71% | Q1 2016 | Q3 2018 | 9 |
PROCEPT BIOROBOTICS CORP | 9 | 9 | 0.04% | 0.27% | 0.47% | Q3 2021 | Q3 2023 | 9 | |
PRTA | PROTHENA CORP PLC | 9 | 9 | 0.11% | 0.26% | 0.44% | Q1 2016 | Q1 2018 | 9 |
STIM | NEURONETICS INC | 9 | 9 | 0.01% | 0.11% | 0.25% | Q2 2018 | Q2 2020 | 9 |
AACH | AAC HLDGS INC | 9 | 9 | 0.03% | 0.07% | 0.19% | Q2 2016 | Q2 2018 | 9 |
MDCO | MEDICINES CO | 6 | 3 | 0.03% | 0.06% | 0.14% | Q1 2017 | Q3 2019 | 9 |
RGNX | REGENXBIO INC | 9 | 9 | 0.01% | 0.06% | 0.15% | Q2 2018 | Q2 2020 | 9 |
PTCT | PTC THERAPEUTICS INC | 8 | 1 | 0.04% | 0.05% | 0.07% | Q1 2016 | Q2 2020 | 9 |
SGRY | SURGERY PARTNERS INC | 9 | 9 | 0.02% | 0.05% | 0.08% | Q1 2016 | Q1 2018 | 9 |
BHVN | BIOHAVEN PHARMACTL HLD... | 7 | 2 | 0.01% | 0.03% | 0.05% | Q4 2019 | Q1 2022 | 9 |
RCUS | ARCUS BIOSCIENCES INC | 9 | 9 | 0.02% | 0.03% | 0.04% | Q4 2020 | Q4 2022 | 9 |
BCYC | BICYCLE THERAPEUTICS PLC | 9 | 9 | 0.01% | 0.02% | 0.03% | Q3 2021 | Q3 2023 | 9 |
FIT | FITBIT INC | 8 | 8 | 0.06% | 0.73% | 1.16% | Q1 2018 | Q4 2019 | 8 |
THC | Tenet Healthcare Corpo... | 4 | 2 | 0.00% | 0.46% | 1.06% | Q1 2016 | Q3 2023 | 8 |
INO | INOVIO PHARMACEUTICALS... | 8 | 8 | 0.06% | 0.20% | 0.42% | Q1 2016 | Q4 2017 | 8 |
JUNO | JUNO THERAPEUTICS INC | 8 | 8 | 0.11% | 0.19% | 0.27% | Q1 2016 | Q4 2017 | 8 |
BNR | BURNING ROCK BIOTECH LTD | 8 | 8 | 0.02% | 0.07% | 0.14% | Q2 2020 | Q1 2022 | 8 |
LUNG | PULMONX CORP | 8 | 8 | 0.04% | 0.07% | 0.14% | Q4 2020 | Q3 2022 | 8 |
AZN | ASTRAZENECA PLC | 8 | 8 | 0.04% | 0.07% | 0.09% | Q4 2021 | Q3 2023 | 8 |
TBPH | THERAVANCE BIOPHARMA INC | 8 | 8 | 0.03% | 0.07% | 0.12% | Q1 2016 | Q4 2017 | 8 |
GTH | GENETRON HLDGS LTD | 8 | 8 | 0.01% | 0.06% | 0.14% | Q2 2020 | Q1 2022 | 8 |
SIGHT SCIENCES INC | 8 | 8 | 0.03% | 0.04% | 0.07% | Q3 2021 | Q2 2023 | 8 | |
ASND | ASCENDIS PHARMA A S | 5 | 3 | 0.02% | 0.04% | 0.12% | Q1 2019 | Q1 2021 | 8 |
DGX | QUEST DIAGNOSTICS INC | 3 | 2 | 0.00% | 0.03% | 0.10% | Q2 2020 | Q3 2023 | 8 |
NTLA | INTELLIA THERAPEUTICS INC | 5 | 3 | 0.01% | 0.02% | 0.04% | Q2 2018 | Q3 2022 | 8 |
KRYS | KRYSTAL BIOTECH INC | 8 | 8 | 0.01% | 0.02% | 0.03% | Q4 2021 | Q3 2023 | 8 |
INBX | INHIBRX INC | 8 | 8 | 0.01% | 0.01% | 0.02% | Q4 2021 | Q3 2023 | 8 |
ZTS | ZOETIS INC | 3 | 2 | 0.00% | 0.01% | 0.02% | Q2 2021 | Q3 2023 | 8 |
FDS | FACTSET RESH SYS INC | 8 | 8 | 0.00% | 0.01% | 0.01% | Q4 2019 | Q3 2021 | 8 |
PKI | PERKINELMER INC | 8 | 8 | 0.00% | 0.01% | 0.01% | Q4 2019 | Q3 2021 | 8 |
TRU | TRANSUNION | 8 | 8 | 0.00% | 0.01% | 0.01% | Q4 2019 | Q3 2021 | 8 |
TCOM | TRIP COM GROUP LTD | 8 | 8 | 0.00% | 0.00% | 0.01% | Q4 2019 | Q3 2021 | 8 |
SCI | SERVICE CORP INTL | 8 | 8 | 0.00% | 0.00% | 0.01% | Q4 2019 | Q3 2021 | 8 |
STZ | CONSTELLATION BRANDS INC | 8 | 8 | 0.00% | 0.00% | 0.01% | Q4 2019 | Q3 2021 | 8 |
DLB | DOLBY LABORATORIES INC | 8 | 8 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q4 2022 | 8 |
ASR | GRUPO AEROPORTUARIO DE... | 8 | 8 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2023 | 8 |
EQIX | EQUINIX INC | 8 | 8 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2023 | 8 |
EVTC | EVERTEC INC | 8 | 8 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2023 | 8 |
INFY | INFOSYS LTD | 8 | 8 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2023 | 8 |
BCR | C.R. Bard, Inc. | 7 | 7 | 0.76% | 1.31% | 2.35% | Q1 2016 | Q3 2017 | 7 |
MNKKQ | MALLINCKRODT PUB LTD CO | 7 | 7 | 0.54% | 0.90% | 1.08% | Q1 2016 | Q3 2017 | 7 |
ADPT | ADAPTIVE BIOTECHNOLOGI... | 7 | 7 | 0.30% | 0.42% | 0.57% | Q2 2021 | Q4 2022 | 7 |
TSRO | TESARO INC | 7 | 7 | 0.10% | 0.35% | 0.82% | Q1 2017 | Q3 2018 | 7 |
IPXL | IMPAX LABORATORIES INC | 4 | 3 | 0.13% | 0.33% | 0.63% | Q1 2016 | Q1 2018 | 7 |
CSTL | CASTLE BIOSCIENCES INC | 7 | 7 | 0.22% | 0.30% | 0.35% | Q1 2022 | Q3 2023 | 7 |
NEO | NEOGENOMICS INC | 7 | 7 | 0.16% | 0.28% | 0.40% | Q2 2020 | Q4 2021 | 7 |
CHNG | CHANGE HEALTHCARE INC | 7 | 7 | 0.19% | 0.26% | 0.38% | Q2 2019 | Q4 2020 | 7 |
HRMY | HARMONY BIOSCIENCES HO... | 7 | 7 | 0.05% | 0.26% | 0.48% | Q3 2021 | Q1 2023 | 7 |
DOCS | DOXIMITY INC | 7 | 7 | 0.05% | 0.14% | 0.22% | Q1 2022 | Q3 2023 | 7 |
CDTX | CIDARA THERAPEUTICS INC | 7 | 7 | 0.06% | 0.11% | 0.15% | Q2 2019 | Q4 2020 | 7 |
CLDX | CELLDEX THERAPEUTICS I... | 7 | 7 | 0.05% | 0.09% | 0.13% | Q1 2016 | Q3 2017 | 7 |
FGEN | FIBROGEN INC | 3 | 2 | 0.02% | 0.05% | 0.15% | Q4 2018 | Q1 2021 | 7 |
CYTK | CYTOKINETICS INC | 7 | 7 | 0.02% | 0.03% | 0.05% | Q1 2022 | Q3 2023 | 7 |
GDX | VANECK ETF TRUST | 7 | 7 | 0.01% | 0.01% | 0.02% | Q1 2022 | Q3 2023 | 7 |
GOOG | ALPHABET INC | 7 | 7 | 0.00% | 0.01% | 0.01% | Q1 2022 | Q3 2023 | 7 |
SQM | SOCIEDAD QUIMICA Y MIN... | 7 | 7 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2020 | 7 |
ADI | ANALOG DEVICES INC | 7 | 7 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q4 2020 | 7 |
ALV | AUTOLIV INC | 7 | 7 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q4 2020 | 7 |
IBKR | INTERACTIVE BROKERS GR... | 7 | 7 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q4 2020 | 7 |
BR | BROADRIDGE FINL SOLUTI... | 7 | 7 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q4 2020 | 7 |
PAYX | PAYCHEX INC | 7 | 7 | 0.00% | 0.01% | 0.01% | Q3 2019 | Q1 2021 | 7 |
CSGP | COSTAR GROUP INC | 7 | 7 | 0.00% | 0.01% | 0.01% | Q1 2020 | Q3 2021 | 7 |
FTNT | FORTINET INC | 7 | 7 | 0.00% | 0.01% | 0.01% | Q2 2020 | Q4 2021 | 7 |
BLKB | BLACKBAUD INC | 7 | 7 | 0.00% | 0.00% | 0.01% | Q2 2019 | Q4 2020 | 7 |
TSM | TAIWAN SEMICONDUCTOR M... | 5 | 2 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2023 | 7 |
CVET | COVETRUS INC | 7 | 7 | 0.00% | 0.00% | 0.00% | Q2 2019 | Q4 2020 | 7 |
UMC | UNITED MICROELECTRONIC... | 5 | 2 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2023 | 7 |
MYOK | MYOKARDIA INC | 6 | 6 | 1.08% | 1.47% | 2.13% | Q2 2019 | Q3 2020 | 6 |
CLDX | CELLDEX THERAPEUTICS I... | 6 | 6 | 0.35% | 0.80% | 1.06% | Q2 2022 | Q3 2023 | 6 |
SGMO | SANGAMO THERAPEUTICS INC | 6 | 6 | 0.48% | 0.54% | 0.67% | Q2 2019 | Q3 2020 | 6 |
QDEL | QUIDEL CORP | 6 | 6 | 0.18% | 0.38% | 0.80% | Q4 2018 | Q1 2020 | 6 |
GTHX | G1 THERAPEUTICS INC | 6 | 6 | 0.12% | 0.25% | 0.35% | Q2 2019 | Q3 2020 | 6 |
LABU | DIREXION SHS ETF TR | 4 | 1 | 0.01% | 0.18% | 0.31% | Q1 2016 | Q1 2020 | 6 |
BIB | ProShares Trust | 4 | 1 | 0.02% | 0.17% | 0.40% | Q1 2016 | Q4 2019 | 6 |
MTLS | MATERIALISE NV | 6 | 6 | 0.04% | 0.15% | 0.28% | Q2 2018 | Q3 2019 | 6 |
KITE | KITE PHARMA INC | 6 | 6 | 0.12% | 0.15% | 0.21% | Q1 2016 | Q2 2017 | 6 |
IMAB | I MAB | 6 | 6 | 0.04% | 0.10% | 0.15% | Q3 2020 | Q4 2021 | 6 |
ARNA | ARENA PHARMACEUTICALS INC | 6 | 6 | 0.02% | 0.08% | 0.12% | Q2 2018 | Q3 2019 | 6 |
NPCE | NEUROPACE INC | 6 | 6 | 0.02% | 0.06% | 0.12% | Q2 2021 | Q3 2022 | 6 |
SNY | SANOFI | 2 | 2 | 0.03% | 0.03% | 0.04% | Q2 2020 | Q2 2022 | 6 |
VRDN | VIRIDIAN THERAPEUTICS INC | 6 | 6 | 0.01% | 0.01% | 0.02% | Q2 2022 | Q3 2023 | 6 |
HTHT | HUAZHU GROUP LTD | 6 | 6 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q3 2020 | 6 |
ADBE | ADOBE SYSTEMS INCORPOR... | 6 | 6 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q3 2020 | 6 |
XLNX | XILINX INC | 6 | 6 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q4 2020 | 6 |
TW | TRADEWEB MKTS INC | 6 | 6 | 0.00% | 0.00% | 0.01% | Q2 2020 | Q3 2021 | 6 |
CYBR | CYBERARK SOFTWARE LTD | 6 | 6 | 0.00% | 0.00% | 0.01% | Q3 2020 | Q4 2021 | 6 |
STNE | STONECO LTD | 6 | 6 | 0.00% | 0.00% | 0.01% | Q3 2020 | Q4 2021 | 6 |
MCHI | ISHARES TR | 6 | 6 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q3 2023 | 6 |
GDXJ | VANECK ETF TRUST | 6 | 6 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q3 2023 | 6 |
AVLR | AVALARA INC | 6 | 6 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2022 | 6 |
WCG | WELLCARE HEALTH PLANS INC | 5 | 5 | 0.02% | 0.79% | 1.59% | Q2 2018 | Q2 2019 | 5 |
QGEN | QIAGEN NV | 5 | 5 | 0.31% | 0.41% | 0.52% | Q1 2016 | Q1 2017 | 5 |
NVDQ | NOVADAQ TECHNOLOGIES INC | 5 | 5 | 0.16% | 0.40% | 0.54% | Q1 2016 | Q1 2017 | 5 |
ACHN | Achillion Pharmaceutic... | 5 | 5 | 0.06% | 0.36% | 0.62% | Q1 2016 | Q1 2017 | 5 |
ZLTQ | ZELTIQ AESTHETICS INC | 5 | 5 | 0.16% | 0.36% | 0.54% | Q1 2016 | Q1 2017 | 5 |
NVAX | NOVAVAX INC | 5 | 5 | 0.06% | 0.20% | 0.44% | Q1 2016 | Q1 2017 | 5 |
LVGO | LIVONGO HEALTH INC | 5 | 5 | 0.01% | 0.18% | 0.39% | Q3 2019 | Q3 2020 | 5 |
CSLT | CASTLIGHT HEALTH INC | 5 | 5 | 0.04% | 0.17% | 0.38% | Q2 2018 | Q2 2019 | 5 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 4 | 1 | 0.02% | 0.11% | 0.19% | Q3 2017 | Q3 2023 | 5 |
AMRX | AMNEAL PHARMACEUTICALS... | 4 | 1 | 0.02% | 0.08% | 0.13% | Q2 2018 | Q4 2019 | 5 |
COTV | COTIVITI HLDGS INC | 5 | 5 | 0.07% | 0.08% | 0.09% | Q2 2017 | Q2 2018 | 5 |
OBLN | OBALON THERAPEUTICS INC | 5 | 5 | 0.03% | 0.05% | 0.07% | Q4 2016 | Q4 2017 | 5 |
BMYRT | BRISTOL-MYERS SQUIBB CO | 5 | 5 | 0.02% | 0.04% | 0.06% | Q4 2019 | Q4 2020 | 5 |
XLRN | ACCELERON PHARMA INC | 3 | 2 | 0.02% | 0.04% | 0.06% | Q3 2018 | Q1 2020 | 5 |
BPMC | BLUEPRINT MEDICINES CORP | 3 | 2 | 0.02% | 0.02% | 0.03% | Q2 2019 | Q1 2022 | 5 |
AKRO | AKERO THERAPEUTICS INC | 5 | 5 | 0.01% | 0.02% | 0.03% | Q3 2022 | Q3 2023 | 5 |
MRUS | MERUS NV | 5 | 5 | 0.01% | 0.01% | 0.02% | Q3 2022 | Q3 2023 | 5 |
SPY | SPDR S&P 500 ETF TRUST | 5 | 5 | 0.01% | 0.01% | 0.02% | Q3 2022 | Q3 2023 | 5 |
XOP | SPDR S&P SER TR | 5 | 5 | 0.01% | 0.01% | 0.01% | Q3 2022 | Q3 2023 | 5 |
POL | POLYONE CORP | 5 | 5 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q2 2020 | 5 |
IT | GARTNER INC | 5 | 5 | 0.00% | 0.01% | 0.01% | Q3 2020 | Q3 2021 | 5 |
MTCH | MATCH GROUP INC NEW | 5 | 5 | 0.00% | 0.01% | 0.01% | Q3 2020 | Q3 2021 | 5 |
ULTA | ULTA BEAUTY INC | 5 | 5 | 0.00% | 0.01% | 0.01% | Q3 2020 | Q3 2021 | 5 |
AKRXQ | AKORN INC | 4 | 4 | 0.68% | 1.39% | 2.06% | Q2 2016 | Q1 2017 | 4 |
PRAH | PRA HEALTH SCIENCES INC | 4 | 4 | 0.86% | 0.99% | 1.16% | Q2 2018 | Q1 2019 | 4 |
ARIA | ARIAD PHARMACEUTICALS INC | 4 | 4 | 0.57% | 0.86% | 1.22% | Q1 2016 | Q4 2016 | 4 |
ALR | ALERE INC | 4 | 4 | 0.23% | 0.41% | 0.77% | Q2 2016 | Q1 2017 | 4 |
AUPH | AURINIA PHARMACEUTICAL... | 4 | 4 | 0.07% | 0.28% | 0.38% | Q1 2022 | Q4 2022 | 4 |
MDSO | MEDIDATA SOLUTIONS INC | 4 | 4 | 0.03% | 0.18% | 0.28% | Q2 2018 | Q1 2019 | 4 |
NTRA | NATERA INC | 4 | 4 | 0.09% | 0.16% | 0.19% | Q4 2022 | Q3 2023 | 4 |
EVHC | ENVISION HEALTHCARE HL... | 4 | 4 | 0.11% | 0.15% | 0.19% | Q2 2016 | Q1 2017 | 4 |
BIVV | BIOVERATIV INC | 4 | 4 | 0.06% | 0.13% | 0.16% | Q1 2017 | Q4 2017 | 4 |
OSCR | OSCAR HEALTH INC | 4 | 4 | 0.06% | 0.11% | 0.15% | Q1 2021 | Q4 2021 | 4 |
WBMD | WEBMD HEALTH CORP | 4 | 4 | 0.05% | 0.06% | 0.08% | Q3 2016 | Q2 2017 | 4 |
ACHC | ACADIA HEALTHCARE COMP... | 2 | 2 | 0.00% | 0.05% | 0.16% | Q3 2017 | Q4 2022 | 4 |
BNFT | BENEFITFOCUS INC | 4 | 4 | 0.03% | 0.04% | 0.06% | Q1 2019 | Q4 2019 | 4 |
MNTA | MOMENTA PHARMACEUTICAL... | 4 | 4 | 0.01% | 0.03% | 0.05% | Q3 2019 | Q2 2020 | 4 |
CVAC | CUREVAC NV | 3 | 1 | 0.02% | 0.02% | 0.03% | Q3 2020 | Q3 2021 | 4 |
KRTX | KARUNA THERAPEUTICS INC | 4 | 4 | 0.02% | 0.02% | 0.03% | Q4 2022 | Q3 2023 | 4 |
ALLK | ALLAKOS INC | 4 | 4 | 0.02% | 0.02% | 0.03% | Q4 2020 | Q3 2021 | 4 |
CCCC | C4 THERAPEUTICS INC | 4 | 4 | 0.01% | 0.02% | 0.02% | Q2 2021 | Q1 2022 | 4 |
ARCT | ARCTURUS THERAPEUTICS ... | 4 | 4 | 0.01% | 0.01% | 0.02% | Q3 2021 | Q2 2022 | 4 |
DNLI | DENALI THERAPEUTICS INC | 4 | 4 | 0.01% | 0.01% | 0.02% | Q3 2022 | Q2 2023 | 4 |
EIGR | EIGER BIOPHARMACEUTICA... | 4 | 4 | 0.01% | 0.01% | 0.01% | Q1 2016 | Q4 2016 | 4 |
CBPO | CHINA BIOLOGIC PRODS H... | 4 | 4 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q1 2020 | 4 |
CL | COLGATE PALMOLIVE CO | 4 | 4 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q1 2020 | 4 |
MTB | M & T BK CORP | 4 | 4 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q1 2020 | 4 |
OLED | UNIVERSAL DISPLAY CORP | 4 | 4 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q4 2021 | 4 |
KTWO | K2M GROUP HLDGS INC | 3 | 3 | 0.96% | 1.13% | 1.25% | Q1 2018 | Q3 2018 | 3 |
BOLD | AUDENTES THERAPEUTICS INC | 3 | 3 | 0.01% | 0.55% | 0.88% | Q2 2019 | Q4 2019 | 3 |
INSYQ | INSYS THERAPEUTICS INC... | 2 | 1 | 0.22% | 0.43% | 0.82% | Q1 2016 | Q4 2016 | 3 |
VRNA | VERONA PHARMA PLC | 3 | 3 | 0.08% | 0.16% | 0.22% | Q1 2023 | Q3 2023 | 3 |
EAR | EARGO INC | 3 | 3 | 0.10% | 0.16% | 0.20% | Q4 2020 | Q2 2021 | 3 |
TMH | Team Health Holdings Inc. | 3 | 3 | 0.11% | 0.13% | 0.15% | Q1 2016 | Q3 2016 | 3 |
CEMP | CEMPRA INC | 3 | 3 | 0.06% | 0.08% | 0.09% | Q1 2017 | Q3 2017 | 3 |
EVHC | ENVISION HEALTHCARE CORP | 3 | 3 | 0.05% | 0.07% | 0.10% | Q2 2017 | Q4 2017 | 3 |
ADAP | ADAPTIMMUNE THERAPEUTI... | 3 | 3 | 0.05% | 0.05% | 0.06% | Q2 2018 | Q4 2018 | 3 |
PINC | PREMIER INC | 3 | 3 | 0.03% | 0.05% | 0.06% | Q3 2018 | Q1 2019 | 3 |
LABD | DIREXION SHS ETF TR | 3 | 3 | 0.03% | 0.05% | 0.08% | Q1 2019 | Q3 2019 | 3 |
AFMD | AFFIMED N V | 3 | 3 | 0.01% | 0.03% | 0.04% | Q4 2018 | Q2 2019 | 3 |
KYMR | KYMERA THERAPEUTICS INC | 3 | 3 | 0.02% | 0.03% | 0.03% | Q3 2021 | Q1 2022 | 3 |
BBIO | BRIDGEBIO PHARMA INC | 3 | 3 | 0.02% | 0.03% | 0.03% | Q1 2023 | Q3 2023 | 3 |
RGEN | REPLIGEN CORP | 2 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q3 2022 | 3 |
DRNA | DICERNA PHARMACEUTICAL... | 3 | 3 | 0.02% | 0.02% | 0.02% | Q4 2020 | Q2 2021 | 3 |
ETNB | 89BIO INC | 3 | 3 | 0.01% | 0.01% | 0.02% | Q1 2023 | Q3 2023 | 3 |
NVCR | NOVOCURE LTD | 2 | 1 | 0.01% | 0.01% | 0.02% | Q1 2022 | Q4 2022 | 3 |
RLMD | RELMADA THERAPEUTICS INC | 3 | 3 | 0.01% | 0.01% | 0.03% | Q1 2022 | Q3 2022 | 3 |
YI | 111 INC | 2 | 1 | 0.01% | 0.01% | 0.02% | Q1 2020 | Q1 2021 | 3 |
VENTYX BIOSCIENCES INC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q1 2023 | Q3 2023 | 3 | |
RCKT | ROCKET PHARMACEUTICALS... | 3 | 3 | 0.01% | 0.01% | 0.02% | Q4 2022 | Q2 2023 | 3 |
AUTL | AUTOLUS THERAPEUTICS PLC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q4 2019 | 3 |
ARWR | ARROWHEAD PHARMACEUTIC... | 3 | 3 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q2 2023 | 3 |
SLN | SILENCE THERAPEUTICS PLC | 3 | 3 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q2 2022 | 3 |
INTU | INTUIT | 3 | 3 | 0.00% | 0.00% | 0.01% | Q1 2021 | Q3 2021 | 3 |
KMX | CARMAX INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q1 2021 | Q3 2021 | 3 |
NYT | NEW YORK TIMES CO | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q4 2021 | 3 |
SPOT | SPOTIFY TECHNOLOGY SA | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q4 2021 | 3 |
STJ | St. Jude Medical, Inc. | 2 | 2 | 0.88% | 1.05% | 1.22% | Q1 2016 | Q2 2016 | 2 |
AMSG | Amsurg Corp | 2 | 2 | 0.86% | 0.97% | 1.08% | Q2 2016 | Q3 2016 | 2 |
Q | QUINTILES IMS HOLDING INC | 2 | 2 | 0.70% | 0.71% | 0.71% | Q2 2017 | Q3 2017 | 2 |
MDVN | Medivation, Inc. | 2 | 2 | 0.53% | 0.71% | 0.88% | Q1 2016 | Q2 2016 | 2 |
AVDR | AVEDRO INC | 2 | 2 | 0.27% | 0.39% | 0.51% | Q1 2019 | Q2 2019 | 2 |
CYH | Community Health Syste... | 2 | 2 | 0.11% | 0.35% | 0.59% | Q1 2016 | Q2 2016 | 2 |
VRX | VALEANT PHARMACEUTICAL... | 2 | 2 | 0.16% | 0.21% | 0.26% | Q1 2018 | Q2 2018 | 2 |
PNT | POINT BIOPHARMA GLOBAL... | 2 | 2 | 0.16% | 0.21% | 0.25% | Q2 2023 | Q3 2023 | 2 |
BHG | BRIGHT HEALTH GROUP INC | 2 | 2 | 0.12% | 0.19% | 0.25% | Q2 2021 | Q3 2021 | 2 |
INFI | Infinity Pharmaceutica... | 2 | 2 | 0.04% | 0.10% | 0.15% | Q1 2016 | Q2 2016 | 2 |
REWALK ROBOTICS LTD | 2 | 2 | 0.06% | 0.09% | 0.12% | Q4 2016 | Q1 2017 | 2 | |
SDC | SMILEDIRECTCLUB INC | 2 | 2 | 0.07% | 0.08% | 0.09% | Q3 2019 | Q4 2019 | 2 |
IRWD | IRONWOOD PHARMACEUTICA... | 2 | 2 | 0.05% | 0.07% | 0.09% | Q3 2018 | Q4 2018 | 2 |
FOLD | AMICUS THERAPEUTICS INC | 2 | 2 | 0.03% | 0.07% | 0.11% | Q1 2019 | Q2 2019 | 2 |
SGFY | SIGNIFY HEALTH INC | 2 | 2 | 0.06% | 0.06% | 0.06% | Q1 2021 | Q2 2021 | 2 |
GOCO | GOHEALTH INC | 2 | 2 | 0.05% | 0.06% | 0.06% | Q3 2020 | Q4 2020 | 2 |
HTWR | Heartware Internationa... | 2 | 2 | 0.03% | 0.03% | 0.04% | Q1 2016 | Q2 2016 | 2 |
ADMS | ADAMAS PHARMACEUTICALS... | 1 | 1 | 0.01% | 0.03% | 0.05% | Q3 2017 | Q3 2019 | 2 |
PCRX | PACIRA BIOSCIENCES INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2022 | Q2 2022 | 2 |
NVAX | NOVAVAX INC | 2 | 2 | 0.02% | 0.02% | 0.03% | Q3 2021 | Q4 2021 | 2 |
ZFGN | Zafgen, Inc. | 2 | 2 | 0.02% | 0.02% | 0.02% | Q1 2016 | Q2 2016 | 2 |
PCVX | VAXCYTE INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q3 2023 | 2 |
ZGNX | ZOGENIX INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q4 2019 | 2 |
QHCCQ | Quorum Health Corp | 2 | 2 | 0.01% | 0.02% | 0.02% | Q2 2016 | Q3 2016 | 2 |
TTPH | Tetraphase Pharmaceuti... | 2 | 2 | 0.02% | 0.02% | 0.02% | Q1 2016 | Q2 2016 | 2 |
ISEE | IVERIC BIO INC | 2 | 2 | 0.01% | 0.02% | 0.02% | Q4 2022 | Q1 2023 | 2 |
VTRS | VIATRIS INC | 1 | 1 | 0.00% | 0.02% | 0.03% | Q4 2020 | Q3 2023 | 2 |
RXRX | RECURSION PHARMACEUTIC... | 1 | 1 | 0.01% | 0.01% | 0.02% | Q2 2021 | Q3 2023 | 2 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 2 | 2 | 0.01% | 0.01% | 0.02% | Q3 2018 | Q4 2018 | 2 |
XENE | XENON PHARMACEUTICALS INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q3 2023 | 2 |
VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q2 2023 | 2 |
IDYA | IDEAYA BIOSCIENCES INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q1 2022 | 2 |
MTCH | MATCH GROUP INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q2 2020 | 2 |
KEX | KIRBY CORP | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q3 2019 | 2 |
CARIBOU BIOSCIENCES INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2022 | Q3 2022 | 2 | |
MCHP | MICROCHIP TECHNOLOGY INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q3 2019 | 2 |
CTRP | CTRIP COM INTL LTD | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q3 2019 | 2 |
DSGN | DESIGN THERAPEUTICS INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2022 | Q4 2022 | 2 |
VNE | VEONEER INCORPORATED | 2 | 2 | 0.00% | 0.01% | 0.01% | Q2 2019 | Q3 2019 | 2 |
AVNT | AVIENT CORPORATION | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q4 2020 | 2 |
GRCL | GRACELL BIOTECHNOLOGIE... | 2 | 2 | 0.00% | 0.01% | 0.01% | Q2 2023 | Q3 2023 | 2 |
NIO | NIO INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q1 2022 | 2 |
BIIB | BIOGEN INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2019 | Q1 2020 | 2 |
NVST | ENVISTA HOLDINGS CORPO... | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q3 2022 | 2 |
CVAC | CUREVAC N V | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2021 | 2 |
ISHARES TR NASDAQ BIOTECH | 1 | 1 | 4.60% | 4.60% | 4.60% | Q4 2018 | Q4 2018 | 1 | |
MDT | Medtronic, Inc. | 1 | 1 | 3.76% | 3.76% | 3.76% | Q1 2016 | Q1 2016 | 1 |
MYL | Mylan Inc. | 1 | 1 | 1.85% | 1.85% | 1.85% | Q1 2016 | Q1 2016 | 1 |
EGBN | Eagle Pharmaceuticals Inc | 1 | 1 | 0.69% | 0.69% | 0.69% | Q1 2016 | Q1 2016 | 1 |
CBPO | CHINA BIOLOGIC PRODS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q2 2017 | Q2 2017 | 1 |
LCI | Lannett Inc. | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2016 | Q1 2016 | 1 |
NUAN | NUANCE COMMUNICATIONS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2021 | Q1 2021 | 1 |
CPHD | Cepheid Inc. | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2016 | Q2 2016 | 1 |
MOLECULAR TEMPLATES INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2023 | Q3 2023 | 1 | |
FMI | FOUNDATION MEDICINE INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2018 | Q2 2018 | 1 |
ABUS | Arbutus Biopharm Corpo... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2016 | Q1 2016 | 1 |
LOXO | LOXO ONCOLOGY INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2018 | Q4 2018 | 1 |
ARRY | ARRAY BIOPHARMA INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2019 | Q1 2019 | 1 |
JNP | Juniper Pharmaceutical... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2016 | Q1 2016 | 1 |
BLCM | BELLICUM PHARMACEUTICA... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2018 | Q2 2018 | 1 |
ECYT | Endocyte, Inc. | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2016 | Q1 2016 | 1 |
UBER | UBER TECHNOLOGIES INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2020 | Q1 2020 | 1 |
PANW | PALO ALTO NETWORKS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2020 | Q1 2020 | 1 |
MLNT | MELINTA THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2017 | Q4 2017 | 1 |
IMGN | ImmunoGen, Inc. | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2016 | Q1 2016 | 1 |
PBYI | PUMA BIOTECHNOLOGY INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2019 | Q1 2019 | 1 |
XOMA | XOMA Corporation | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2016 | Q1 2016 | 1 |
RYTM | RHYTHM PHARMACEUTICALS... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2023 | Q3 2023 | 1 |
VIR | VIR BIOTECHNOLOGY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2020 | Q2 2020 | 1 |
GERN | Geron Corporation | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2016 | Q1 2016 | 1 |
CERT | CERTARA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 |
CERS | CERUS CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2017 | Q1 2017 | 1 |
IMCR | IMMUNOCORE HLDGS PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 |
ANAB | ANAPTYSBIO INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2019 | Q2 2019 | 1 |
STRUCTURE THERAPEUTICS... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 | |
GE HEALTHCARE TECHNOLO... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 | |
EARS | AURIS MED HLDG AG | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2018 | Q2 2018 | 1 |
ZYME | ZYMEWORKS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q1 2020 | 1 |
FDMT | 4D MOLECULAR THERAPEUT... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q2 2023 | 1 |
DICE THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q2 2023 | 1 | |
GLPG | GALAPAGOS NV | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
NARI | INARI MED INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2020 | Q2 2020 | 1 |
GILD | GILEAD SCIENCES INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 |
ACIU | AC IMMUNE SA | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q3 2021 | 1 |
PTGX | PROTAGONIST THERAPEUTI... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 |
BIS | PROSHARES TR | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q2 2019 | 1 |
LIN | LINDE PLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q3 2019 | 1 |
STML | STEMLINE THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q3 2019 | 1 |
BLU | BELLUS HEALTH INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 |
CRM | SALESFORCE COM INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q2 2019 | 1 |
USB | US BANCORP DEL | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q2 2019 | 1 |
AST | Asterias Biotherapeuti... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2016 | Q1 2016 | 1 |
ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2019 | Q3 2019 | 1 |
GLPG | GALAPAGOS NV | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 |
ABCM | ABCAM PLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2023 | Q2 2023 | 1 |
ABBV | ABBVIE INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 |
BTXWS | Biotime Inc. | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2016 | Q1 2016 | 1 |
PDD | PINDUODUO INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2022 | Q1 2022 | 1 |
BILI | BILIBILI INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2022 | Q1 2022 | 1 |
Download |
The securities at the top of the list , including IONIS PHARMACEUTICALS INC, Vertex Pharmaceuticals Incorporated, and NEUROCRINE BIOSCIENCES INC, are the highest-conviction holdings of Bellevue Group AG.
The conviction is calculated by counting the number of quarters a security has been reported by Bellevue Group AG. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Bellevue Group AG owns currently or has owned in the past.